Mastalgia in infertility: search for additional possibilities of therapy

Aim. To assess the efficacy and safety of using the homeopathic drug Mastopol for the relief of mastalgia in women with infertility, including those associated with endometriosis, as well as to study the drug tolerability and adherence to the treatment, as well as to determine its antiproliferative...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ksenia V. Krasnopolskaya, Vera E. Balan, Irina Y. Ershova, Elena O. Skorik, Sergey E. Malygin, Mekan R. Orazov, Lilia R. Toktar, Elena V. Lagutina
Formato: article
Lenguaje:RU
Publicado: IP Berlin A.V. 2021
Materias:
Acceso en línea:https://doaj.org/article/0e6c1354f5a14999ae7fc97c0ec91a9c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0e6c1354f5a14999ae7fc97c0ec91a9c
record_format dspace
spelling oai:doaj.org-article:0e6c1354f5a14999ae7fc97c0ec91a9c2021-12-02T19:22:24ZMastalgia in infertility: search for additional possibilities of therapy2079-56962079-583110.26442/20795696.2021.4.201084https://doaj.org/article/0e6c1354f5a14999ae7fc97c0ec91a9c2021-09-01T00:00:00Zhttps://gynecology.orscience.ru/2079-5831/article/viewFile/80424/60966https://doaj.org/toc/2079-5696https://doaj.org/toc/2079-5831Aim. To assess the efficacy and safety of using the homeopathic drug Mastopol for the relief of mastalgia in women with infertility, including those associated with endometriosis, as well as to study the drug tolerability and adherence to the treatment, as well as to determine its antiproliferative and analgesic effects in patients of the study cohort. Study design: open-label, randomized, non-comparative, observational study. Material and methods. 79 infertile women with mastalgia (67 with cyclic mastalgia and 12 with acyclic mastalgia) were examined and treated with Mastopol. Mastopol was prescribed 1 tablet 3 times a day sublingually. The course of treatment was 8 weeks. The efficacy of mastalgia relief was assessed using a Visual Analogue Scale (VAS). Treatment outcomes were considered good if pain severity by the VAS decreased by 4 or more points from the baseline levels at the end of Mastopol treatment course. Results. One Mastopol treatment course provided good treatment outcomes in 76,2% of patients with cyclic mastalgia and in 33,3% of patients with acyclic mastalgia. There were no adverse reactions or complications in patients treated with Mastopol. Conclusions. Mastopol has established itself as a quite effective and safe drug in patients of the study cohort; if there is an insufficient effect, Mastopol can supplement traditional pharmacological agents recorded in the current clinical guidelines.Ksenia V. KrasnopolskayaVera E. BalanIrina Y. ErshovaElena O. SkorikSergey E. MalyginMekan R. OrazovLilia R. ToktarElena V. LagutinaIP Berlin A.V. articlemastalgiainfertilitymastopolGynecology and obstetricsRG1-991RUГинекология, Vol 23, Iss 4, Pp 354-363 (2021)
institution DOAJ
collection DOAJ
language RU
topic mastalgia
infertility
mastopol
Gynecology and obstetrics
RG1-991
spellingShingle mastalgia
infertility
mastopol
Gynecology and obstetrics
RG1-991
Ksenia V. Krasnopolskaya
Vera E. Balan
Irina Y. Ershova
Elena O. Skorik
Sergey E. Malygin
Mekan R. Orazov
Lilia R. Toktar
Elena V. Lagutina
Mastalgia in infertility: search for additional possibilities of therapy
description Aim. To assess the efficacy and safety of using the homeopathic drug Mastopol for the relief of mastalgia in women with infertility, including those associated with endometriosis, as well as to study the drug tolerability and adherence to the treatment, as well as to determine its antiproliferative and analgesic effects in patients of the study cohort. Study design: open-label, randomized, non-comparative, observational study. Material and methods. 79 infertile women with mastalgia (67 with cyclic mastalgia and 12 with acyclic mastalgia) were examined and treated with Mastopol. Mastopol was prescribed 1 tablet 3 times a day sublingually. The course of treatment was 8 weeks. The efficacy of mastalgia relief was assessed using a Visual Analogue Scale (VAS). Treatment outcomes were considered good if pain severity by the VAS decreased by 4 or more points from the baseline levels at the end of Mastopol treatment course. Results. One Mastopol treatment course provided good treatment outcomes in 76,2% of patients with cyclic mastalgia and in 33,3% of patients with acyclic mastalgia. There were no adverse reactions or complications in patients treated with Mastopol. Conclusions. Mastopol has established itself as a quite effective and safe drug in patients of the study cohort; if there is an insufficient effect, Mastopol can supplement traditional pharmacological agents recorded in the current clinical guidelines.
format article
author Ksenia V. Krasnopolskaya
Vera E. Balan
Irina Y. Ershova
Elena O. Skorik
Sergey E. Malygin
Mekan R. Orazov
Lilia R. Toktar
Elena V. Lagutina
author_facet Ksenia V. Krasnopolskaya
Vera E. Balan
Irina Y. Ershova
Elena O. Skorik
Sergey E. Malygin
Mekan R. Orazov
Lilia R. Toktar
Elena V. Lagutina
author_sort Ksenia V. Krasnopolskaya
title Mastalgia in infertility: search for additional possibilities of therapy
title_short Mastalgia in infertility: search for additional possibilities of therapy
title_full Mastalgia in infertility: search for additional possibilities of therapy
title_fullStr Mastalgia in infertility: search for additional possibilities of therapy
title_full_unstemmed Mastalgia in infertility: search for additional possibilities of therapy
title_sort mastalgia in infertility: search for additional possibilities of therapy
publisher IP Berlin A.V.
publishDate 2021
url https://doaj.org/article/0e6c1354f5a14999ae7fc97c0ec91a9c
work_keys_str_mv AT kseniavkrasnopolskaya mastalgiaininfertilitysearchforadditionalpossibilitiesoftherapy
AT veraebalan mastalgiaininfertilitysearchforadditionalpossibilitiesoftherapy
AT irinayershova mastalgiaininfertilitysearchforadditionalpossibilitiesoftherapy
AT elenaoskorik mastalgiaininfertilitysearchforadditionalpossibilitiesoftherapy
AT sergeyemalygin mastalgiaininfertilitysearchforadditionalpossibilitiesoftherapy
AT mekanrorazov mastalgiaininfertilitysearchforadditionalpossibilitiesoftherapy
AT liliartoktar mastalgiaininfertilitysearchforadditionalpossibilitiesoftherapy
AT elenavlagutina mastalgiaininfertilitysearchforadditionalpossibilitiesoftherapy
_version_ 1718376719635709952